Show simple item record

dc.contributor.authorMiddleton, MR
dc.contributor.authorSteven, NM
dc.contributor.authorEvans, TJ
dc.contributor.authorInfante, JR
dc.contributor.authorHamid, O
dc.contributor.authorShoushtari, AN
dc.contributor.authorCorrie, P
dc.contributor.authorAnthoney, A
dc.contributor.authorGupta, Avinash
dc.contributor.authorWoodcock, VK
dc.contributor.authorMcAlpine, C
dc.contributor.authorSznol, M
dc.date.accessioned2020-03-27T09:28:05Z
dc.date.available2020-03-27T09:28:05Z
dc.date.issued2020en
dc.identifier.citationMiddleton MR, Steven NM, Evans TJ, Infante JR, Hamid O, Shoushtari AN, et al. Pharmacodynamic effect of tebentafusp (TCR-CD3 bispecific) on peripheral cytokines and association with overall survival in patients with advanced melanoma. Journal of Translational Medicine. 2020;18en
dc.identifier.urihttp://hdl.handle.net/10541/622853
dc.language.isoenen
dc.titlePharmacodynamic effect of tebentafusp (TCR-CD3 bispecific) on peripheral cytokines and association with overall survival in patients with advanced melanomaen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Oncology, Medical Sciences Division, University of Oxford, Oxford,en
dc.identifier.journalJournal of Translational Medicineen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record